Xiang S - Search Results

1

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation.

Zhou S, Han Y, Li J, Pi X, Lyu J, Xiang S, Zhou X, Chen X, Wang Z, Yang R. Zhou S, et al. Among authors: xiang s. Front Oncol. 2021 Oct 13;11:745384. doi: 10.3389/fonc.2021.745384. eCollection 2021. Front Oncol. 2021. PMID: 34722301 Free PMC article.

2

UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways.

Zhou S, Ouyang W, Zhang X, Liao L, Pi X, Yang R, Mei B, Xu H, Xiang S, Li J. Zhou S, et al. Among authors: xiang s. Cancer Cell Int. 2021 Feb 4;21(1):88. doi: 10.1186/s12935-021-01768-4. Cancer Cell Int. 2021. PMID: 33632212 Free PMC article.

3

Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.

Yang RH, Liang B, Li JH, Pi XB, Yu K, Xiang SJ, Gu N, Chen XD, Zhou ST. Yang RH, et al. J Cell Mol Med. 2021 Dec;25(23):10990-11001. doi: 10.1111/jcmm.17021. Epub 2021 Nov 10. J Cell Mol Med. 2021. PMID: 34755462 Free PMC article.

4

The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study.

Xiang S, Zeng H, Xia F, Ji Q, Xue J, Ren R, Que F, Zhou B. Xiang S, et al. Life Sci. 2021 Jan 1;264:118598. doi: 10.1016/j.lfs.2020.118598. Epub 2020 Nov 12. Life Sci. 2021. PMID: 33189818

5

SIRT6 Promotes Osteogenic Differentiation of Adipose-Derived Mesenchymal Stem Cells Through Antagonizing DNMT1.

Jia B, Chen J, Wang Q, Sun X, Han J, Guastaldi F, Xiang S, Ye Q, He Y. Jia B, et al. Among authors: xiang s. Front Cell Dev Biol. 2021 Jun 22;9:648627. doi: 10.3389/fcell.2021.648627. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34239868 Free PMC article.

6

Alisol B 23-Acetate Ameliorates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Inhibiting TLR4-NOX1/ROS Signaling Pathway in Caco-2 Cells.

Xia F, Li Y, Deng L, Ren R, Ge B, Liao Z, Xiang S, Zhou B. Xia F, et al. Among authors: xiang s. Front Pharmacol. 2022 Jun 14;13:911196. doi: 10.3389/fphar.2022.911196. eCollection 2022. Front Pharmacol. 2022. PMID: 35774596 Free PMC article.

7

Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway.

Xiang S, Jian L, Zeng H, Wu H, Ge B, Zhang P, Lin J, Guo A, Zhou B. Xiang S, et al. Biochem Pharmacol. 2023 Dec;218:115859. doi: 10.1016/j.bcp.2023.115859. Epub 2023 Oct 18. Biochem Pharmacol. 2023. PMID: 37863326 Free article.

8

LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway.

Jia B, Dao J, Han J, Huang Z, Sun X, Zheng X, Xiang S, Zhou H, Liu S. Jia B, et al. Among authors: xiang s. Cancer Cell Int. 2021 Mar 3;21(1):147. doi: 10.1186/s12935-021-01808-z. Cancer Cell Int. 2021. PMID: 33658048 Free PMC article.

9

Metabolomic Mechanisms of Radix Fici Hirtae against Carbon Tetrachloride-Induced Acute Liver Damage in Mice.

Zhou FY, Quan T, Xiang SJ, Li H, Chen HY, Yang YX, Li SS. Zhou FY, et al. Evid Based Complement Alternat Med. 2022 May 17;2022:9157465. doi: 10.1155/2022/9157465. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35620409 Free PMC article.

10

Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.

Yang M, Chen Z, Xiang S, Xia F, Tang W, Yao X, Zhou B. Yang M, et al. Among authors: xiang s. BMC Complement Med Ther. 2020 Dec 11;20(1):377. doi: 10.1186/s12906-020-03164-3. BMC Complement Med Ther. 2020. PMID: 33308192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,182 results

Search Page

Filters